ArticleJournal of cellular and molecular medicine2020

PLA2G16 is a mutant p53/KLF5 transcriptional target and promotes glycolysis of pancreatic cancer.

Wei Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.